Optimising testosterone therapy in patients with hypoactive sexual desire disorder
British Journal of General Practice · 2025-04 · 75 (753) · 189-190
DOI: 10.3399/bjgp25x741321 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of General Practice, online erschienen am 27.03.2025. Verfasst von Stephen M Gibbons und 5 weiteren Autor:innen. Beteiligte Einrichtung: Leeds Teaching Hospitals NHS Trust, Leeds. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
What is hypoactive sexual desire disorder?Hypoactive sexual desire disorder (HSDD) presents a persistent absence or deficiency of sexual fantasies and desire, in some individuals leading to significant distress or interpersonal difficulty.
Autor:innen und Institutionen
- Leeds Teaching Hospitals NHS Trust, Leeds.
- North Leeds Medical Practice, Leeds.
- The Meanwood Group Practice, Leeds.
Zitieren
APA
Gibbons, S. M., Jassim, B., Spencer, C., Bailey, K., Haynes, E., & Ward, E. (2025). Optimising testosterone therapy in patients with hypoactive sexual desire disorder. British Journal of General Practice, 75(753), 189-190. https://doi.org/10.3399/bjgp25x741321
Vancouver
Gibbons SM, Jassim B, Spencer C, Bailey K, Haynes E, Ward E. Optimising testosterone therapy in patients with hypoactive sexual desire disorder. British Journal of General Practice. 2025;75(753):189-190. doi:10.3399/bjgp25x741321
BibTeX
@article{Gibbons2025,
author = {Gibbons, Stephen M and Jassim, Borislava and Spencer, Clare and Bailey, Keir and Haynes, Eloise and Ward, Emma},
title = {Optimising testosterone therapy in patients with hypoactive sexual desire disorder},
journal = {British Journal of General Practice},
year = {2025},
volume = {75},
number = {753},
pages = {189--190},
doi = {10.3399/bjgp25x741321}
}
EUVIMED